What is the step-by-step management pathway for hypokalaemia in primary care,

Guideline-aligned answer with reasoning, red flags and references. Clinically reviewed by Dr Kola Tytler MBBS CertHE MBA MSt MRCGP.

Posted: 27 July 2026Updated: 27 July 2026 Guideline-Aligned (High Confidence) Clinically Reviewed

Definitions and immediate triage: Hypokalaemia is serum potassium below 3.5 mmol/L; mild is 3.0–3.4 mmol/L, moderate is 2.5–2.9 mmol/L, and severe is below 2.5 mmol/L.

Biochemical severity may not reflect clinical severity, because symptoms and ECG abnormalities determine immediate risk.

Immediately admit to hospital if potassium is below 2.5 mmol/L, if there are symptoms (especially dysrhythmia, paralysis, respiratory failure, or severe weakness), or if there are clinical signs of hypovolaemia, thyrotoxic crisis, metabolic acidosis or alkalosis, hyperosmolar hyperglycaemic state, diabetic ketoacidosis, or severe below 0.5 mmol/L or symptomatic hypomagnesaemia.

Red flags requiring acute referral include rhabdomyolysis, progressive severe weakness or paralysis, respiratory muscle weakness, paralytic ileus, and cardiac dysrhythmias.

Step 1 — confirm and risk-assess: Repeat serum potassium promptly on a timescale determined by clinical judgement to exclude a spurious result and identify a rapidly falling potassium concentration, which requires hospital admission.

Request urea and electrolytes including potassium, chloride, sodium and magnesium, plus glucose, creatinine and bicarbonate.

Check magnesium because hypokalaemia may only correct after magnesium correction; hypomagnesaemia is defined here as below 0.75 mmol/L.

Perform an ECG and seek ST-segment depression, reduced T-wave amplitude, prominent U waves, and QT prolongation.

Also assess for sinus bradycardia, atrial or ventricular ectopy, atrial or junctional tachycardia, atrioventricular block, ventricular tachycardia, or ventricular fibrillation.

Step 2 — focused history, examination and differential: Take a detailed medication and treatment history, specifically considering thiazide or loop diuretics, beta-agonists, insulin and corticosteroids.

Ask about vomiting or diarrhoea, alcohol misuse, poor intake, fasting, hypocaloric or unbalanced diets, eating disorders, hot-climate exercise, chronic liquorice ingestion, polydipsia and nocturnal polyuria.

Assess for potassium shifts or endocrine causes, including metabolic alkalosis, increased beta-adrenergic activity such as thyrotoxicosis or phaeochromocytoma, increased insulin secretion, primary hyperaldosteronism and hypercortisolism.

Ask about cardiac, renal or hepatic disease, family history of hypokalaemia, and factors suggesting concurrent hypomagnesaemia.

Examine blood pressure, heart rate and volume status, and look for dehydration, malnutrition, abdominal distension or tenderness or features of obstruction, reduced power, hypotonia, reduced reflexes, goitre or other signs of thyrotoxicosis.

Mild hypokalaemia (3.0–3.4 mmol/L): People are often asymptomatic when this has developed slowly and there are no dysrhythmia risk factors; management in primary care is appropriate if no referral criteria are present.

For observation and cause-directed management, treat the suspected cause, stop a causative medicine where appropriate, or increase dietary potassium where poor intake is suspected, then recheck potassium after 2 weeks or sooner if clinically indicated.

Consider oral potassium replacement rather than observation alone when replacement is clinically indicated, while addressing the cause and monitoring serum electrolytes.

For potassium between 3 and 4 mmol/L, the Sando-K SmPC advises considering a maximum daily dose of 50–100 mmol potassium, equivalent to 4–8 tablets, with dosing regulated by clinical response and serum electrolytes and acid–base studies.

Administer Sando-K orally after dissolving the tablets in water; it may be taken with food.

Correct coexistent hypomagnesaemia with oral magnesium supplementation.

Moderate hypokalaemia (2.5–2.9 mmol/L): If asymptomatic, discuss the need for specialist referral; primary-care management is only appropriate when referral is not required.

Use the same cause-directed measures, medication review, magnesium correction and repeat potassium strategy as for mild hypokalaemia, with earlier reassessment according to clinical judgement because a rapidly declining result requires admission.

Consider oral potassium replacement; for potassium between 2 and 3 mmol/L, the Sando-K SmPC advises considering a maximum daily dose of 100–200 mmol potassium, equivalent to 8–16 tablets, titrated to serum electrolytes and acid–base studies.

Discuss or refer where there is cardiac, renal or hepatic disease, an uncertain cause, or any clinical/ECG concern.

Severe hypokalaemia (below 2.5 mmol/L), symptomatic hypokalaemia, or ECG abnormality: This requires emergency hospital admission and urgent potassium replacement rather than community oral-management pathways.

Hospital treatment may require intravenous potassium replacement when serum potassium is below 2 mmol/L, according to the Sando-K SmPC.

IV fluids and electrolytes should be prescribed and administered by skilled, competent professionals using an IV-fluid management plan with assessment and monitoring.

Follow-up and escalation: For primary-care-managed mild or moderate hypokalaemia, repeat potassium after 2 weeks following cause-directed intervention, or sooner on clinical grounds; repeat earlier immediately when the result may be spurious or potassium may be falling rapidly.

Investigate further and consider referral if the cause remains unclear.

Related Knowledge Topics

Educational content only. Always verify information and use clinical judgement.